In this episode of Expose MASH [formerly NASH]—intended for US healthcare professionals only— we discuss the role that advanced practice providers (APPs) play in the screening and identification of patients with MASH (metabolic dysfunction-associated steatohepatitis). We explore their influence on patient care, their role in coordinating care, and discuss how their involvement in the MASH patient journey can impact patient outcomes. This episode is brought to you by Novo Nordisk Inc.